首页 > 市场调查报告书 > 汽车工业

运输/物流

市场调查报告书

商品编码

1582938

药品物流市场 - 全球产业规模、份额、趋势、机会和预测，按类型、组成部分、地区和竞争细分，2019-2029F

Pharmaceutical Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Component, By Region and Competition, 2019-2029F

出版日期: 2024年10月30日 | 出版商:

TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023年全球医药物流市场价值为932.3亿美元，预计2029年将达到1,408.3亿美元，预测期内复合年增长率为7.09%。

市场概况
预测期	2025-2029
2023 年市场规模	932.3亿美元
2029 年市场规模	1408.3亿美元
2024-2029 年复合年增长率	7.09%
成长最快的细分市场	冷链物流
最大的市场	北美洲

由于对高效供应链解决方案的需求不断增长，以确保及时交付药品和医疗保健产品，全球药品物流市场正在经历显着增长。随着电子商务的兴起，物流业正在适应製药公司和消费者的需求，提高整个供应链的可见度和追踪能力。监管合规性在这个市场中至关重要，因为药品需要遵守严格的安全和品质标准。因此，物流供应商正在投资温控运输、先进的包装解决方案和专门的处理流程，以确保产品从製造到最终用户交付的完整性。生物製剂和生物相似药的激增通常需要特定的储存条件，这进一步刺激了对专业物流服务的需求。 COVID-19 大流行凸显了弹性供应链的至关重要性，导致对物流基础设施和技术的投资增加。公司越来越多地利用自动化、人工智慧和资料分析来优化路线、降低成本并改善服务交付。市场也正在见证向永续实践的转变，物流提供者实施环保解决方案以最大限度地减少碳足迹。从地理位置来看，由于大型製药公司的存在和先进的物流基础设施，北美在医药物流市场占据主导地位。在医疗保健行业扩张和可支配收入增加的推动下，亚太地区正在迅速崛起。药品製造商和物流服务提供者之间的合作对于应对全球供应链的复杂性至关重要。随着製药领域的不断发展，物流市场必须适应新兴趋势，确保患者及时、安全地获得基本药物，同时保持遵守监管要求。这种动态环境为整个医学流生态系统的利害关係人带来了挑战和机会。

主要市场驱动因素

药品需求增加

电子商务成长

技术进步

生物製剂和生物相似药的兴起

主要市场挑战

温度控制

永续发展压力

主要市场趋势

更加重视冷链物流

电子商务扩张

细分市场洞察

类型洞察

区域洞察

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 93.23 Billion
Market Size 2029	USD 140.83 Billion
CAGR 2024-2029	7.09%
Fastest Growing Segment	Cold chain logistics
Largest Market	North America

The Global Pharmaceutical Logistics Market is experiencing significant growth, driven by the increasing demand for efficient supply chain solutions to ensure the timely delivery of medications and healthcare products. With the rise of e-commerce, the logistics sector is adapting to meet the needs of both pharmaceutical companies and consumers, enhancing visibility and tracking capabilities throughout the supply chain. Regulatory compliance is paramount in this market, as pharmaceutical products are subject to stringent safety and quality standards. Consequently, logistics providers are investing in temperature-controlled transportation, advanced packaging solutions, and specialized handling processes to ensure product integrity from manufacturing to end-user delivery. The proliferation of biologics and biosimilars, which often require specific storage conditions, is further fueling demand for specialized logistics services. COVID-19 pandemic highlighted the critical importance of resilient supply chains, leading to increased investment in logistics infrastructure and technology. Companies are increasingly utilizing automation, artificial intelligence, and data analytics to optimize routes, reduce costs, and improve service delivery. The market is also witnessing a shift towards sustainable practices, with logistics providers implementing eco-friendly solutions to minimize their carbon footprint. Geographically, North America dominates the pharmaceutical logistics market due to the presence of major pharmaceutical companies and advanced logistics infrastructure. Asia-Pacific region is emerging rapidly, driven by expanding healthcare sectors and rising disposable incomes. Collaboration between pharmaceutical manufacturers and logistics service providers is crucial for navigating the complexities of global supply chains. As the pharmaceutical landscape continues to evolve, the logistics market must adapt to emerging trends, ensuring that patients receive essential medications promptly and safely while maintaining compliance with regulatory requirements. This dynamic environment presents both challenges and opportunities for stakeholders across the pharmaceutical logistics ecosystem.

Key Market Drivers

Increasing Demand for Pharmaceuticals

The increasing demand for pharmaceuticals is a significant driver of growth in the Global Pharmaceutical Logistics Market. As the prevalence of chronic diseases rises alongside an aging population, the need for timely access to medications has never been greater. This heightened demand compels pharmaceutical companies to enhance their supply chain efficiency, ensuring that products are delivered promptly and in optimal condition. Logistics providers play a crucial role in this process, offering specialized services that cater to the unique requirements of pharmaceuticals, including temperature-controlled transportation and secure storage. For instance, in September 2024, MD Logistics, a subsidiary of NIPPON EXPRESS HOLDINGS, announced the transformation of an 18,500m2 area in its Plainfield, Indiana warehouse into a state-of-the-art facility dedicated to life sciences and pharmaceuticals. This upgraded facility aims to enhance the quality of pharmaceutical logistics services, catering specifically to the needs of the industry. The rapid expansion of e-commerce in the pharmaceutical sector necessitates advanced logistics solutions to facilitate direct-to-consumer deliveries. As healthcare systems evolve to meet patient needs, the demand for reliable, efficient, and compliant logistics services will continue to escalate, driving innovation and investment in the pharmaceutical logistics sector. This trend underscores the critical importance of logistics in ensuring patient access to essential medications.

E-commerce Growth

The growth of e-commerce is reshaping the Global Pharmaceutical Logistics Market, creating new opportunities and challenges for logistics providers. The rise of online pharmacies and direct-to-consumer models, accelerated by the COVID-19 pandemic, has significantly increased the demand for efficient logistics solutions. Consumers now expect swift and reliable delivery of medications, necessitating advanced supply chain management practices that can handle the complexities of e-commerce, such as real-time tracking, order fulfillment, and last-mile delivery. The need for compliance with regulatory requirements, particularly for prescription medications, adds another layer of complexity to pharmaceutical logistics. As e-commerce continues to expand, logistics providers are increasingly investing in technology and infrastructure to enhance their capabilities, ensuring that they can meet consumer demands while maintaining the integrity and safety of pharmaceutical products. This trend not only fosters innovation within the logistics sector but also emphasizes the critical role of efficient distribution in improving patient access to essential healthcare products. For instance, in 2022, Agility Logistics announced the merger of its digital freight forwarding division, Shipa Freight, with Barcelona-based iContainers. This strategic move aims to strengthen Agility's position in the digital logistics sector by combining the technological capabilities and expertise of both companies. The merger is expected to enhance service offerings, streamline operations, and expand market reach, particularly in Europe and other key regions. By integrating Shipa Freight's digital platforms with iContainers' established network, Agility aims to provide more efficient, customer-centric solutions for international freight forwarding, catering to the evolving needs of businesses in an increasingly digital and globalized market.

Technological Advancements

Technological advancements are revolutionizing the Global Pharmaceutical Logistics Market by enhancing efficiency, transparency, and reliability throughout the supply chain. Innovations such as automation, artificial intelligence (AI), and the Internet of Things (IoT) are transforming traditional logistics practices. Automated systems streamline inventory management, reducing errors and optimizing stock levels, while AI algorithms analyze data to improve demand forecasting and route optimization. IoT devices enable real-time tracking of shipments, ensuring temperature-sensitive medications are maintained within required conditions, thus preserving their efficacy. The blockchain technology offers enhanced traceability and security, allowing stakeholders to verify the authenticity of pharmaceutical products and comply with regulatory standards. As logistics providers increasingly adopt these technologies, they can offer more responsive and agile services, ultimately improving the delivery of pharmaceuticals to patients. This technological evolution not only enhances operational efficiency but also fosters greater trust among consumers and healthcare providers, further driving growth in the pharmaceutical logistics sector.

Rise of Biologics and Biosimilars

The rise of biologics and biosimilars is a significant factor driving growth in the Global Pharmaceutical Logistics Market. Biologics, which are complex molecules derived from living organisms, and their biosimilar counterparts require specialized handling and storage conditions to maintain their integrity and efficacy. This demand for meticulous logistics solutions necessitates temperature-controlled transportation and advanced packaging techniques, ensuring that these sensitive products remain stable throughout the supply chain. As the prevalence of chronic diseases and autoimmune disorders increases, the demand for biologics is expected to grow, prompting pharmaceutical companies to seek reliable logistics partners adept at managing these complexities. The regulatory landscape surrounding biologics and biosimilars is stringent, necessitating compliance with Good Distribution Practices (GDP). As logistics providers adapt to these challenges, they play a critical role in facilitating access to these innovative therapies, ensuring that patients receive timely and safe deliveries of essential biologic and biosimilar medications.

Key Market Challenges

Temperature Control

Temperature control is a critical aspect of the Global Pharmaceutical Logistics Market, especially for the transportation and storage of temperature-sensitive products such as biologics, vaccines, and certain medications. Maintaining the required temperature range throughout the supply chain is essential to ensure the efficacy and safety of these products. Any deviation from the specified temperature can compromise the integrity of the pharmaceuticals, leading to potential patient safety risks and financial losses for manufacturers. This necessity has prompted logistics providers to invest in advanced temperature-controlled solutions, including refrigerated trucks, insulated containers, and state-of-the-art monitoring systems that track temperatures in real time.

The regulatory bodies have established stringent guidelines for the handling of temperature-sensitive pharmaceuticals, compelling logistics companies to adopt Good Distribution Practices (GDP). The challenges in achieving effective temperature control are compounded by factors such as geographical disparities, unreliable infrastructure, and climate variations. As the demand for temperature-sensitive pharmaceuticals continues to rise, particularly with the growing focus on biologics and vaccines, the need for robust temperature-controlled logistics solutions becomes increasingly paramount. Consequently, the industry must innovate and implement best practices to ensure compliance, reliability, and the safe delivery of critical healthcare products to patients globally.

Sustainability Pressure

Sustainability pressure is increasingly shaping the Global Pharmaceutical Logistics Market as stakeholders demand environmentally responsible practices throughout the supply chain. As public awareness of climate change and environmental issues grows, pharmaceutical companies, logistics providers, and consumers are advocating for greener operations. This pressure is leading logistics firms to adopt sustainable practices, such as optimizing transportation routes to reduce fuel consumption, utilizing electric and hybrid vehicles, and implementing energy-efficient warehouse solutions. The use of eco-friendly packaging materials is gaining traction, with companies exploring biodegradable and recyclable options to minimize waste. Regulatory bodies are also contributing to this shift by introducing guidelines and incentives for sustainable practices within the pharmaceutical industry. However, achieving sustainability poses challenges, as logistics providers must balance environmental goals with operational efficiency and cost-effectiveness. The complexities of managing temperature-sensitive products further complicate these efforts, as maintaining the necessary conditions for pharmaceuticals often requires energy-intensive solutions. As the market evolves, companies that prioritize sustainability can differentiate themselves, enhancing their brand image and meeting consumer expectations. Ultimately, the integration of sustainable practices in pharmaceutical logistics is not only a response to external pressures but also a crucial step toward ensuring long-term viability and resilience in a rapidly changing global landscape.

Key Market Trends

Increased Focus on Cold Chain Logistics

The increased focus on cold chain logistics is a pivotal trend in the Global Pharmaceutical Logistics Market, primarily driven by the rising demand for temperature-sensitive products such as biologics, vaccines, and certain pharmaceuticals. Maintaining the integrity and efficacy of these products throughout the supply chain is crucial, as any deviation from the required temperature range can lead to compromised quality and potential patient safety risks. This has led pharmaceutical companies to prioritize robust cold chain solutions, investing in advanced refrigerated transportation, insulated packaging, and real-time temperature monitoring systems. For instance, a leading Indian pharmaceutical manufacturer faced cargo movement and compliance issues due to multiple third-party locations without factory-stuffing permissions. Agility solved this by consolidating cargo at its GDP-certified Pharma Competency Center (PCC) in Nhava Sheva, improving supply chain control, compliance, container utilization, and cost savings.

The COVID-19 pandemic has heightened awareness of the importance of cold chain logistics, especially with the rapid development and distribution of vaccines that require stringent temperature controls. As a result, logistics providers are enhancing their capabilities by implementing sophisticated tracking technologies and automated systems that ensure compliance with Good Distribution Practices (GDP). This increased focus on cold chain logistics not only improves the reliability of product delivery but also fosters greater trust among stakeholders in the pharmaceutical supply chain. Ultimately, as the demand for biologics and other temperature-sensitive products continues to grow, the emphasis on cold chain logistics will remain a critical component in ensuring the safe and effective delivery of essential healthcare products to patients globally.

E-commerce Expansion

E-commerce expansion is significantly reshaping the Global Pharmaceutical Logistics Market, driven by changing consumer behaviors and the increasing demand for convenient access to medications. The rise of online pharmacies and direct-to-consumer models has accelerated this trend, particularly during the COVID-19 pandemic, when many consumers turned to online platforms for their healthcare needs. This shift requires logistics providers to develop agile and efficient supply chain solutions that can handle the complexities of e-commerce, such as order fulfillment, last-mile delivery, and rapid response to customer needs. To meet these demands, companies are investing in technology-driven solutions, including automated warehousing and advanced inventory management systems, to ensure timely and accurate deliveries. Maintaining compliance with regulations surrounding the sale and distribution of pharmaceuticals online presents unique challenges, prompting logistics providers to enhance their operational capabilities. The need for secure and temperature-controlled shipping is paramount, especially for prescription medications and biologics. As e-commerce continues to grow, logistics providers must adapt to meet the expectations of consumers for fast, reliable, and safe delivery of pharmaceuticals. This trend not only improves accessibility to essential medications but also fosters a more competitive landscape within the pharmaceutical logistics sector, driving innovation and efficiency.

Segmental Insights

Type Insights

Based on the type, Cold chain logistics has dominated the Global Pharmaceutical Logistics Market due to the critical need for maintaining the integrity and efficacy of temperature-sensitive products. The increasing prevalence of biologics, vaccines, and specialty pharmaceuticals-many of which require strict temperature controls-has underscored the importance of reliable cold chain solutions. These products are often susceptible to degradation if not stored and transported within specific temperature ranges, making effective cold chain management essential for ensuring patient safety and compliance with regulatory standards. The recent global health crises, particularly the COVID-19 pandemic, highlighted the necessity of robust cold chain systems for vaccine distribution, which necessitated precise temperature management to maintain effectiveness. As a result, pharmaceutical companies are increasingly prioritizing partnerships with logistics providers that specialize in cold chain solutions, investing in advanced technologies such as real-time temperature monitoring, insulated packaging, and specialized refrigerated transport.

Regional Insights

North America dominated the Global Pharmaceutical Logistics Market due to several key factors. The region is home to major pharmaceutical companies, which drive high demand for efficient logistics solutions. Advanced infrastructure, including well-developed transportation networks and state-of-the-art cold chain facilities, enhances logistical efficiency. The stringent regulatory requirements necessitate high compliance standards, prompting investments in specialized logistics services. The presence of a robust e-commerce framework further supports pharmaceutical distribution. The ongoing innovations in technology, such as automation and real-time tracking, position North America as a leader in pharmaceutical logistics, ensuring timely and reliable delivery of medications.

Key Market Players

Agility
United Parcel Service of America, Inc.
VersaCold Logistics Services
CEVA Logistics
Air Canada
DB SCHENKER
Deutsche Post AG
FedEx
LifeConEx
Marken

Report Scope:

In this report, the Global Pharmaceutical Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Logistics Market, By Type:

Cold Chain Logistics
Non-Cold Chain Logistics

Pharmaceutical Logistics Market, By Component:

Storage
Transportation
Monitoring components

Pharmaceutical Logistics Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Logistics Market.

Available Customizations:

Global Pharmaceutical Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Logistics Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (Cold Chain Logistics, Non-Cold Chain Logistics)
- 5.2.2. By Component (Storage, Transportation, Monitoring components)
- 5.2.3. By Region
- 5.2.4. By Company (2023)
5.3. Market Map

6. North America Pharmaceutical Logistics Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Component
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Pharmaceutical Logistics Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Component
- 6.3.2. Canada Pharmaceutical Logistics Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Component
- 6.3.3. Mexico Pharmaceutical Logistics Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Component

7. Europe Pharmaceutical Logistics Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Component
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Pharmaceutical Logistics Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Component
- 7.3.2. United Kingdom Pharmaceutical Logistics Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Component
- 7.3.3. Italy Pharmaceutical Logistics Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Component
- 7.3.4. France Pharmaceutical Logistics Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Component
- 7.3.5. Spain Pharmaceutical Logistics Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Component

8. Asia-Pacific Pharmaceutical Logistics Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Component
- 8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Pharmaceutical Logistics Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Component
- 8.3.2. India Pharmaceutical Logistics Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Component
- 8.3.3. Japan Pharmaceutical Logistics Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Component
- 8.3.4. South Korea Pharmaceutical Logistics Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Component
- 8.3.5. Australia Pharmaceutical Logistics Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Component

9. South America Pharmaceutical Logistics Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Component
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Pharmaceutical Logistics Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Component
- 9.3.2. Argentina Pharmaceutical Logistics Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Component
- 9.3.3. Colombia Pharmaceutical Logistics Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Component

10. Middle East and Africa Pharmaceutical Logistics Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Component
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Pharmaceutical Logistics Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Component
- 10.3.2. Saudi Arabia Pharmaceutical Logistics Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Component
- 10.3.3. UAE Pharmaceutical Logistics Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Component

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porter's Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Agility
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. United Parcel Service of America, Inc.
14.3. VersaCold Logistics Services
14.4. CEVA Logistics
14.5. Air Canada
14.6. DB SCHENKER
14.7. Deutsche Post AG
14.8. FedEx
14.9. LifeConEx
14.10. Marken